Target intelligence / Profile preview

Long intergenic non-protein coding RNA 226 (LINC00226)

Target
LINC00226
Molecular classification
Long non-coding RNA, Intergenic lncRNA, Other
01

Overview

Long intergenic non-protein coding RNA 226 (LINC00226) is a human long non-coding RNA (lncRNA) that does not encode a protein but plays a regulatory role at the genomic and epigenetic levels[1][3][5]. It is located on chromosome 14q32.33 and consists of at least two exons[1][7]. LINC00226 has been implicated in diverse biological processes, including regulation of gene expression and chromatin structure, and is associated with various pathological conditions such as cancer, where its altered copy number or expression can influence tumorigenesis and potentially serve as a biomarker for diagnosis or prognosis. While it shows relevance in cancers such as glioblastoma, penile cancer, and chronic lymphocytic leukemia, as well as a potential role in male infertility, there is no strong evidence that it functions as a direct therapeutic target (e.g., not a receptor, enzyme, or transporter), and there are no known drugs targeting LINC00226 currently[3][5][7]. Its specific mechanisms of action in disease contexts remain under investigation, and further studies are needed to clarify its clinical implications.

Other names
C14orf97NCRNA00226ENSG00000276210ENST00000611530
02

Biological functions

Regulation of gene expressionEpigenetic regulationChromatin remodelingPossible involvement in cell proliferation, invasion, apoptosis, and autophagy
03

Disease associations

Cancer (e.g., glioblastoma, penile cancer, pancreatic ductal adenocarcinoma, chronic lymphocytic leukemia)Infertility/reproductive biology (spermatogenesis)
04

Biomarkers

Prognostic biomarker in certain cancers (e.g., LINC00226 amplification or deletion linked to prognosis in glioblastoma, penile cancer, chronic lymphocytic leukemia)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 226 (LINC00226).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 226 (LINC00226).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call